First Health Pharmaceuticals is proud to be part of AVITHRAPID, the European Community funded public-private consortium for preparedness against potential pandemic viruses. Viral diseases represent…
morava
On this World AIDS Day global leaders, WHO, NGOs and citizens join forces to address the importance of tackling the HIV epidemics in order to…
Our new oncology patent WO2022180080 was approved and is already available in the WIPO database. The patent protects a new generation of antitumor agents with…
Since the publication of our Reservoir Reducing results by our partners of the Erasmus Medical Center in Nature Communications last year, several new studies by…
It is with great sadness that we have to communicate the death of our dear friend and co-founder of First Health Pharmaceuticals, F. Wouter (Mickey)…
DISCLAIMER: Fraud Recruitment Offers ! Please be aware of a job scam circulating on behalf of First Health Pharmaceuticals B.V. Don’t apply to any…
A study led by First Health Pharmaceuticals B.V. (FHPBV) and the Italian Institute of oncological research and prevention (ISPRO), together with the University of Siena…
Since the beginning of the pandemic, First Health Pharmaceuticals has extended its commitment to the finding of a cure for CoViD-19 also, alongside its main research focus…
Today, the prestigious scientific journal Nature Communications published the article “Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir”.…
Besides our Research and Development in The Netherlands, First Health Pharmaceuticals has important collaborations worldwide, especially in countries such as India and Italy. Recently we…